Neurocrine Bioscience buy Deutsche Bank Aktiengesellschaft
Start price
12.12.23
/
50%
€111.60
Target price
12.12.24
€126.18
Performance (%)
17.11%
Price
03.05.24
€130.70
Summary
This prediction is currently active. The BUY prediction by Deutsche_Bank_Aktien currently has a performance of 17.11%. This prediction currently runs until 12.12.24. The prediction end date can be changed by Deutsche_Bank_Aktien at any time. Deutsche_Bank_Aktien has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Neurocrine Bioscience | 2.873% | 2.873% |
iShares Core DAX® | -0.922% | -1.993% |
iShares Nasdaq 100 | 0.371% | -0.868% |
iShares Nikkei 225® | 2.224% | -5.187% |
iShares S&P 500 | -0.026% | -0.918% |
Comments by Deutsche_Bank_Aktien for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating and a $136.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat